GlassScriptPhysician profile
Kellie Ham Mclain
NPI 1811005788
$28,340.23
in general payments reported to CMS, 2019-2025
9 companies · $840 in 2025
The $840 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,878 · 2022: $12K · 2023: $1,050 · 2024: $11K · 2025: $840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,610 · Travel and Lodging: $2,572 · Food and Beverage: $1,136 · Consulting Fee: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,610.00 |
| Travel and Lodging | $2,571.83 |
| Food and Beverage | $1,135.94 |
| Consulting Fee | $840.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $24,071.78 | 2021-2025 | Nexletol, Nexlizet |
| Regeneron Healthcare Solutions, INC. | $3,042.85 | 2022 | |
| Novartis Pharmaceuticals Corporation | $687.50 | 2022 | |
| Cvrx, INC. | $166.95 | 2021-2023 | Barostim Neo System |
| Boston Scientific Corporation | $149.39 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.64 | 2023 | Lifevest |
| Amgen INC. | $63.10 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.50 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $30.52 | 2022-2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Mclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.